Randomized comparison of the cost and effectiveness of iopamidol and diatrizoate as contrast agents for cardiac angiography
Authors:
- Mark A. HlatkyMHMark A. Hlatky
- Kenneth G. MorrisKMKenneth G. Morris
- Karen S. PieperKPKaren S. Pieper
- Charles J. DavidsonCDCharles J. Davidson
- Steve J. SchwabSSSteve J. Schwab
- Thomas M. BashoreTBThomas M. Bashore
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Contrast Nephrotoxicity: A Randomized Controlled Trial of a Nonionic and an Ionic Radiographic Contrast AgentNew England Journal of Medicine, 1989
- Cardiovascular and Renal Toxicity of a Nonionic Radiographic Contrast Agent after Cardiac CatheterizationAnnals of Internal Medicine, 1989
- The Introduction of Low-Osmolar Contrast Agents in RadiologyJAMA, 1988
- Cost vs Safety The Use of Low-Osmolar Contrast MediaJAMA, 1988
- New Intravascular Contrast MaterialArchives of internal medicine (1960), 1986
- Comparison of the electrocardiographic and hemodynamic responses to ionic and nonionic radiocontrast media during left ventriculography: A randomized double-blind studyAmerican Heart Journal, 1986
- Changes in left ventricular diastolic function after left ventriculography: A comparison with iopamidol and urografinAmerican Heart Journal, 1985
- Absence of myocardial biochemical toxicity with a nonionic contrast agent (iopamidol)American Heart Journal, 1985
- Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiographyJACC, 1985
- Contrast agents in angiocardiography.Heart, 1984